Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CKD-510
/
Novartis
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
CKD-510
/
Novartis
Trial completion:
A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects
(clinicaltrials.gov) - Mar 15, 2023
P1
, N=16, Completed,
Sponsor: Chong Kun Dang Pharmaceutical
Recruiting --> Completed
||
||||||||
CKD-510
/
Novartis
New P1 trial:
A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects
(clinicaltrials.gov) - Sep 2, 2022
P1
, N=16, Recruiting,
Sponsor: Chong Kun Dang Pharmaceutical
|||
|||||||
CKD-510
/
Novartis
Trial completion:
Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects
(clinicaltrials.gov) - May 4, 2022
P1
, N=87, Completed,
Sponsor: Chong Kun Dang Pharmaceutical
Recruiting --> Completed Active, not recruiting --> Completed
|||
|||||||
CKD-510
/
Novartis
New P1 trial:
Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects
(clinicaltrials.gov) - Feb 8, 2021
P1
, N=88, Active, not recruiting,
Sponsor: Chong Kun Dang Pharmaceutical